0 Bewertungen
ID

41517

Beschreibung

Study Title: LEOSS: Lean European Open Survey on SARS-CoV-2 Infected Patients https://leoss.net Study Indication: COVID-19 Date: 14.10.2020, 15:22 Published with permission by Prof. Dr. med. J.-J. Vehreschild. LEOSS is mandated by the ESCMID Emerging Infections Task Force (EITaF) and supported by the German Infectious Disease Society. It aims at a better understanding of the implications of the new virus on patients by systematically documenting patient data across Europe (Text adapted from leoss.net). For more information please visit the official website. This document is for Immunsuppressive drug-related data. If a text field can't be filled out, note 'ND' (for not determined).

Link

https://leoss.net

Stichworte

Versionen (2)
  1. 30.10.20 30.10.20 -
  2. 07.05.21 07.05.21 -
Rechteinhaber

LEOSS

Hochgeladen am

30. Oktober 2020

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

  • Neueste
  • Älteste
  • Beliebt
  • Neueste
    • Neueste
    • Älteste
    • Beliebt

    Keine Kommentare

    Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

    LEOSS: Lean European Open Survey on SARS-CoV-2 Infected Patients

    Englisch

    Immunsuppressive drug-related data

    1 Formulare  
    Antibodies: Anti-CD20
    Beschreibung

    Antibodies: Anti-CD20

    Alias
    UMLS CUI-1
    C3891557
    Obinutuzumab (in the last 6 months)
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C2742503
    UMLS CUI [1,2]
    C0332185
    Ocrelizumab (in the last 6 months)
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C1882138
    UMLS CUI [1,2]
    C0332185
    Ofatumumab (in the last 3 months)
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C1832027
    UMLS CUI [1,2]
    C0332185
    Rituximab (in the last 6 months)
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C0393022
    UMLS CUI [1,2]
    C0332185
    Antibodies: CD-22
    Beschreibung

    Antibodies: CD-22

    Alias
    UMLS CUI-1
    C0003241
    UMLS CUI-2
    C0054947
    Inotuzumab-Ozogamicin
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C1567130
    Antibodies: CD-38
    Beschreibung

    Antibodies: CD-38

    Alias
    UMLS CUI-1
    C0003241
    UMLS CUI-2
    C0075742
    Daratumumab
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C2346801
    Antibodies: CD-52
    Beschreibung

    Antibodies: CD-52

    Alias
    UMLS CUI-1
    C0003241
    UMLS CUI-2
    C1610534
    Alemtuzumab (in the last 12 months)
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C0383429
    UMLS CUI [1,2]
    C0332185
    Antibodies: Anti-CD79b
    Beschreibung

    Antibodies: Anti-CD79b

    Alias
    UMLS CUI-1
    C0104979
    UMLS CUI-2
    C0003241
    Polatuzumab-Vedotin
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C4078806
    Antibodies: B Lymphocyte stimulator-specific inhibitor (BLyS)
    Beschreibung

    Antibodies: B Lymphocyte stimulator-specific inhibitor (BLyS)

    Alias
    UMLS CUI-1
    C0003241
    UMLS CUI-2
    C3160093
    Belimumab (in the last 6 months)
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C1723401
    UMLS CUI [1,2]
    C0332185
    Antibodies: CD19-BiTE
    Beschreibung

    Antibodies: CD19-BiTE

    Alias
    UMLS CUI-1
    C0003241
    UMLS CUI-2
    C4727095
    Blinatumomab
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C3853839
    Antibodies: Complement inhibitors
    Beschreibung

    Antibodies: Complement inhibitors

    Alias
    UMLS CUI-1
    C0003241
    UMLS CUI-2
    C1564892
    Crovalimab
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C1564892
    UMLS CUI [1,2]
    C3846158
    Eculizumab
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C1541483
    Pegcetacoplan (APL-2)
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C4053680
    Ravulizumab
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C4550350
    Antibodies: Co-stimulation inhibitors
    Beschreibung

    Antibodies: Co-stimulation inhibitors

    Alias
    UMLS CUI-1
    C0003241
    UMLS CUI-2
    C1622572
    UMLS CUI-3
    C1999216
    Abatacept
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C1619966
    Belatacept
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C1619962
    Antibodies: Integrin antagonists
    Beschreibung

    Antibodies: Integrin antagonists

    Alias
    UMLS CUI-1
    C0003241
    UMLS CUI-2
    C2917367
    Natalizumab
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C1172734
    Vedolizumab
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C2742797
    Antibodies: Interleukin inhibitors
    Beschreibung

    Antibodies: Interleukin inhibitors

    Alias
    UMLS CUI-1
    C3653320
    UMLS CUI-2
    C0003241
    Basiliximab
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0676831
    Canakinumab
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C2718773
    Ixekizumab
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C3489764
    Sarilumab
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C3885145
    Secukinumab
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C3179547
    Tocilizumab
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C1609165
    Ustekinumab
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C1608841
    Antibodies: TNF-alpha inhibitors
    Beschreibung

    Antibodies: TNF-alpha inhibitors

    Alias
    UMLS CUI-1
    C3653350
    UMLS CUI-2
    C0003241
    Adalimumab
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C1122087
    Certolizumab
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C1872109
    Etanercept
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0717758
    Golimumab
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C2353893
    Infliximab
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0666743
    Other Antibodies
    Beschreibung

    Other Antibodies

    Alias
    UMLS CUI-1
    C0003241
    UMLS CUI-2
    C0205394
    Other Antibodies
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C0003241
    UMLS CUI [1,2]
    C0205394
    Other, please specify:
    Beschreibung

    Other Antibodies, to specify

    Datentyp

    text

    Alias
    UMLS CUI [1,1]
    C0205394
    UMLS CUI [1,2]
    C1521902
    UMLS CUI [1,3]
    C0003241
    Chemotherapeutics: Antimetabolites
    Beschreibung

    Chemotherapeutics: Antimetabolites

    Alias
    UMLS CUI-1
    C0003376
    UMLS CUI-2
    C0729502
    6-Mercaptopurine
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0000618
    Azathioprine
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0004482
    Leflunomide
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0063041
    Methotrexate
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0025677
    Mycophenolate mofetil / Mycophenolic acid
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0209368
    UMLS CUI [2]
    C0026933
    Sulfasalazine
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0036078
    Teriflunomide
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C1718383
    Chemotherapeutics: Cytostatics
    Beschreibung

    Chemotherapeutics: Cytostatics

    Alias
    UMLS CUI-1
    C0010858
    UMLS CUI-2
    C0729502
    Cladribine (2-CDA) i.v./s.c. (in the last 12 months)
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C0092801
    UMLS CUI [1,2]
    C0348016
    UMLS CUI [1,3]
    C0332185
    UMLS CUI [2,1]
    C0092801
    UMLS CUI [2,2]
    C0021499
    UMLS CUI [2,3]
    C0332185
    Cladribine (2-CDA) p.o. (in the last 12 months)
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C0092801
    UMLS CUI [1,2]
    C0001563
    UMLS CUI [1,3]
    C0332185
    Cyclophosphamide i.v.(in the last 3 months)
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C0010583
    UMLS CUI [1,2]
    C0348016
    UMLS CUI [1,3]
    C0332185
    Cyclophosphamide p.o. (in the last 3 months)
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C0010583
    UMLS CUI [1,2]
    C0001563
    UMLS CUI [1,3]
    C0332185
    Mitoxantrone (in the last 3 months)
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C0026259
    UMLS CUI [1,2]
    C0332185
    Other Chemotherapeutics
    Beschreibung

    Other Chemotherapeutics

    Alias
    UMLS CUI-1
    C0205394
    UMLS CUI-2
    C0729502
    Other Chemotherapeutics
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C0205394
    UMLS CUI [1,2]
    C0729502
    Other, please specify:
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    text

    Alias
    UMLS CUI [1,1]
    C0729502
    UMLS CUI [1,2]
    C0205394
    UMLS CUI [1,3]
    C1521902
    Inhibitors: Calcineurin inhibitors
    Beschreibung

    Inhibitors: Calcineurin inhibitors

    Alias
    UMLS CUI-1
    C1562036
    Ciclosporin
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0010592
    Pimecrolimus
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C1099414
    Tacrolimus
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0085149
    Inhibitors: Interleukin inhibitor
    Beschreibung

    Inhibitors: Interleukin inhibitor

    Alias
    UMLS CUI-1
    C3653320
    Anakinra
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0245109
    Inhibitors: JAK inhibitors
    Beschreibung

    Inhibitors: JAK inhibitors

    Alias
    UMLS CUI-1
    C3854325
    Baricitinib
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C4044947
    Fedratinib
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C3886623
    Ruxolitinib
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C2931926
    Tofacitinib
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C2930696
    Upadacitinib
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C4726929
    Inhibitors: mTOR inhibitors
    Beschreibung

    Inhibitors: mTOR inhibitors

    Alias
    UMLS CUI-1
    C2746052
    Everolimus
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0541315
    Sirolimus
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0072980
    Inhibitor: PDE-4-inhibitor
    Beschreibung

    Inhibitor: PDE-4-inhibitor

    Alias
    UMLS CUI-1
    C2936609
    Apremilast
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C1678805
    Other Inhibitors
    Beschreibung

    Other Inhibitors

    Alias
    UMLS CUI-1
    C0205394
    UMLS CUI-2
    C0243077
    Other inhibitors
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C0205394
    UMLS CUI [1,2]
    C0243077
    Other, please specify
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    text

    Alias
    UMLS CUI [1,1]
    C0205394
    UMLS CUI [1,2]
    C1521902
    UMLS CUI [1,3]
    C0243077
    Other immunsuppressive regimens: Corticosteroids
    Beschreibung

    Other immunsuppressive regimens: Corticosteroids

    Alias
    UMLS CUI-1
    C0021081
    UMLS CUI-2
    C0205394
    UMLS CUI-3
    C0001617
    < 10 mg / d prednisolone equivalent
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C0445550
    UMLS CUI [1,2]
    C0038317
    10 - 100 mg / d prednisolone equivalent
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0038317
    > 100 mg / d prednisolone equivalent
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C0038317
    UMLS CUI [1,2]
    C0444956
    Other immunsuppressive regimens: Fumarate
    Beschreibung

    Other immunsuppressive regimens: Fumarate

    Alias
    UMLS CUI-1
    C0021081
    UMLS CUI-2
    C0205394
    UMLS CUI-3
    C0220833
    Dimethyl fumarate
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0058218
    Dimethyl fumarate / ethyl hydrogen fumarate
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0058218
    UMLS CUI [2]
    C0059764
    Other immunsuppressive regimens: Immunosuppressive / immunomodulatory regimens
    Beschreibung

    Other immunsuppressive regimens: Immunosuppressive / immunomodulatory regimens

    Alias
    UMLS CUI-1
    C1963758
    UMLS CUI-2
    C0205394
    UMLS CUI-3
    C0021081
    Immunoglobulins i.v.
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C0021027
    UMLS CUI [1,2]
    C0348016
    Immunoglobulins s.c.
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C0021027
    UMLS CUI [1,2]
    C0021499
    Other immunsuppressive regimens: Interferon
    Beschreibung

    Other immunsuppressive regimens: Interferon

    Alias
    UMLS CUI-1
    C0021081
    UMLS CUI-2
    C0205394
    UMLS CUI-3
    C3652465
    Interferon-alpha
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0002199
    Interferon-beta
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0015980
    Other Immunsuppressive regimens: Other MS drugs
    Beschreibung

    Other Immunsuppressive regimens: Other MS drugs

    Alias
    UMLS CUI-1
    C0021081
    UMLS CUI-2
    C0205394
    UMLS CUI-3
    C0013227
    UMLS CUI-4
    C0026769
    Glatirameracetat
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0289884
    Other Immunsuppressive regimens: Sphingosine-1-phosphate receptor modulators
    Beschreibung

    Other Immunsuppressive regimens: Sphingosine-1-phosphate receptor modulators

    Alias
    UMLS CUI-1
    C0021081
    UMLS CUI-2
    C0205394
    UMLS CUI-3
    C4760638
    Fingolimod
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C1699926
    Siponimod
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C3657824
    Other immunosuppressive regimens: Other
    Beschreibung

    Other immunosuppressive regimens: Other

    Alias
    UMLS CUI-1
    C0205394
    UMLS CUI-2
    C0021081
    Other Immunsuppressive agents
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C0021081
    UMLS CUI [1,2]
    C0205394
    Other, please specify
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    text

    Alias
    UMLS CUI [1,1]
    C0021081
    UMLS CUI [1,2]
    C0205394
    UMLS CUI [1,3]
    C1521902
    Immunosuppressive drugs: Underlying disease
    Beschreibung

    Immunosuppressive drugs: Underlying disease

    Alias
    UMLS CUI-1
    C0021081
    UMLS CUI-2
    C0277554
    Multiple Sclerosis
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0026769
    Other neurological autoimmune diseases
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C0205494
    UMLS CUI [1,2]
    C0004364
    UMLS CUI [1,3]
    C0205394
    Oncology
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0205478
    Organ transplantation
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0029216
    Rheumatic diseases
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C3495832
    Other Underlying disease
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C0277554
    UMLS CUI [1,2]
    C0205394
    Other, please specify:
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C0277554
    UMLS CUI [1,2]
    C0205394
    UMLS CUI [1,3]
    C1521902
    Unknown underlying disease
    Beschreibung

    Note: This question is critical for the further course of the questionnaire.

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C0439673
    UMLS CUI [1,2]
    C0277554
    Is data entry for this section finished?
    Beschreibung

    Is data entry for this section finished?

    Alias
    UMLS CUI-1
    C4684556
    UMLS CUI-2
    C1828479
    UMLS CUI-3
    C0205197
    Is data entry for this section finished?
    Beschreibung

    Is data entry for this section finished?

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C4684556
    UMLS CUI [1,2]
    C1828479
    UMLS CUI [1,3]
    C0205197
    Zum Seitenanfang zurückkehren

    Ähnliche Modelle

    Immunsuppressive drug-related data

    1 Formulare
    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datentyp
    Alias
    Item Group
    Antibodies: Anti-CD20
    C3891557 (UMLS CUI-1)
    Item
    Obinutuzumab (in the last 6 months)
    integer
    C2742503 (UMLS CUI [1,1])
    C0332185 (UMLS CUI [1,2])
    Obinutuzumab (in the last 6 months)
    Code List
    Obinutuzumab (in the last 6 months)
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Ocrelizumab (in the last 6 months)
    integer
    C1882138 (UMLS CUI [1,1])
    C0332185 (UMLS CUI [1,2])
    Ocrelizumab (in the last 6 months)
    Code List
    Ocrelizumab (in the last 6 months)
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Ofatumumab (in the last 3 months)
    integer
    C1832027 (UMLS CUI [1,1])
    C0332185 (UMLS CUI [1,2])
    Ofatumumab (in the last 3 months)
    Code List
    Ofatumumab (in the last 3 months)
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Rituximab (in the last 6 months)
    integer
    C0393022 (UMLS CUI [1,1])
    C0332185 (UMLS CUI [1,2])
    Rituximab (in the last 6 months)
    Code List
    Rituximab (in the last 6 months)
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item Group
    Antibodies: CD-22
    C0003241 (UMLS CUI-1)
    C0054947 (UMLS CUI-2)
    Item
    Inotuzumab-Ozogamicin
    integer
    C1567130 (UMLS CUI [1])
    Inotuzumab-Ozogamicin
    Code List
    Inotuzumab-Ozogamicin
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item Group
    Antibodies: CD-38
    C0003241 (UMLS CUI-1)
    C0075742 (UMLS CUI-2)
    Item
    Daratumumab
    integer
    C2346801 (UMLS CUI [1])
    Daratumumab
    Code List
    Daratumumab
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item Group
    Antibodies: CD-52
    C0003241 (UMLS CUI-1)
    C1610534 (UMLS CUI-2)
    Item
    Alemtuzumab (in the last 12 months)
    integer
    C0383429 (UMLS CUI [1,1])
    C0332185 (UMLS CUI [1,2])
    Alemtuzumab (in the last 12 months)
    Code List
    Alemtuzumab (in the last 12 months)
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item Group
    Antibodies: Anti-CD79b
    C0104979 (UMLS CUI-1)
    C0003241 (UMLS CUI-2)
    Item
    Polatuzumab-Vedotin
    integer
    C4078806 (UMLS CUI [1])
    Polatuzumab-Vedotin
    Code List
    Polatuzumab-Vedotin
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item Group
    Antibodies: B Lymphocyte stimulator-specific inhibitor (BLyS)
    C0003241 (UMLS CUI-1)
    C3160093 (UMLS CUI-2)
    Item
    Belimumab (in the last 6 months)
    integer
    C1723401 (UMLS CUI [1,1])
    C0332185 (UMLS CUI [1,2])
    Belimumab (in the last 6 months)
    Code List
    Belimumab (in the last 6 months)
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item Group
    Antibodies: CD19-BiTE
    C0003241 (UMLS CUI-1)
    C4727095 (UMLS CUI-2)
    Item
    Blinatumomab
    integer
    C3853839 (UMLS CUI [1])
    Blinatumomab
    Code List
    Blinatumomab
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item Group
    Antibodies: Complement inhibitors
    C0003241 (UMLS CUI-1)
    C1564892 (UMLS CUI-2)
    Item
    Crovalimab
    integer
    C1564892 (UMLS CUI [1,1])
    C3846158 (UMLS CUI [1,2])
    Crovalimab
    Code List
    Crovalimab
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Eculizumab
    integer
    C1541483 (UMLS CUI [1])
    Eculizumab
    Code List
    Eculizumab
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Pegcetacoplan (APL-2)
    integer
    C4053680 (UMLS CUI [1])
    Pegcetacoplan (APL-2)
    Code List
    Pegcetacoplan (APL-2)
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Ravulizumab
    integer
    C4550350 (UMLS CUI [1])
    Ravulizumab
    Code List
    Ravulizumab
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item Group
    Antibodies: Co-stimulation inhibitors
    C0003241 (UMLS CUI-1)
    C1622572 (UMLS CUI-2)
    C1999216 (UMLS CUI-3)
    Item
    Abatacept
    integer
    C1619966 (UMLS CUI [1])
    Abatacept
    Code List
    Abatacept
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Belatacept
    integer
    C1619962 (UMLS CUI [1])
    Belatacept
    Code List
    Belatacept
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item Group
    Antibodies: Integrin antagonists
    C0003241 (UMLS CUI-1)
    C2917367 (UMLS CUI-2)
    Item
    Natalizumab
    integer
    C1172734 (UMLS CUI [1])
    Natalizumab
    Code List
    Natalizumab
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Vedolizumab
    integer
    C2742797 (UMLS CUI [1])
    Vedolizumab
    Code List
    Vedolizumab
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item Group
    Antibodies: Interleukin inhibitors
    C3653320 (UMLS CUI-1)
    C0003241 (UMLS CUI-2)
    Item
    Basiliximab
    integer
    C0676831 (UMLS CUI [1])
    Basiliximab
    Code List
    Basiliximab
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Canakinumab
    integer
    C2718773 (UMLS CUI [1])
    Canakinumab
    Code List
    Canakinumab
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Ixekizumab
    integer
    C3489764 (UMLS CUI [1])
    Ixekizumab
    Code List
    Ixekizumab
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Sarilumab
    integer
    C3885145 (UMLS CUI [1])
    Sarilumab
    Code List
    Sarilumab
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Secukinumab
    integer
    C3179547 (UMLS CUI [1])
    Secukinumab
    Code List
    Secukinumab
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Tocilizumab
    integer
    C1609165 (UMLS CUI [1])
    Tocilizumab
    Code List
    Tocilizumab
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Ustekinumab
    integer
    C1608841 (UMLS CUI [1])
    Ustekinumab
    Code List
    Ustekinumab
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item Group
    Antibodies: TNF-alpha inhibitors
    C3653350 (UMLS CUI-1)
    C0003241 (UMLS CUI-2)
    Item
    Adalimumab
    integer
    C1122087 (UMLS CUI [1])
    Adalimumab
    Code List
    Adalimumab
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Certolizumab
    integer
    C1872109 (UMLS CUI [1])
    Certolizumab
    Code List
    Certolizumab
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Etanercept
    integer
    C0717758 (UMLS CUI [1])
    Etanercept
    Code List
    Etanercept
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Golimumab
    integer
    C2353893 (UMLS CUI [1])
    Golimumab
    Code List
    Golimumab
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Infliximab
    integer
    C0666743 (UMLS CUI [1])
    Infliximab
    Code List
    Infliximab
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item Group
    Other Antibodies
    C0003241 (UMLS CUI-1)
    C0205394 (UMLS CUI-2)
    Item
    Other Antibodies
    integer
    C0003241 (UMLS CUI [1,1])
    C0205394 (UMLS CUI [1,2])
    Other Antibodies
    Code List
    Other Antibodies
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Other Antibodies, to specify
    Item
    Other, please specify:
    text
    C0205394 (UMLS CUI [1,1])
    C1521902 (UMLS CUI [1,2])
    C0003241 (UMLS CUI [1,3])
    Item Group
    Chemotherapeutics: Antimetabolites
    C0003376 (UMLS CUI-1)
    C0729502 (UMLS CUI-2)
    Item
    6-Mercaptopurine
    integer
    C0000618 (UMLS CUI [1])
    6-Mercaptopurine
    Code List
    6-Mercaptopurine
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Azathioprine
    integer
    C0004482 (UMLS CUI [1])
    Azathioprine
    Code List
    Azathioprine
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Leflunomide
    integer
    C0063041 (UMLS CUI [1])
    Leflunomide
    Code List
    Leflunomide
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Methotrexate
    integer
    C0025677 (UMLS CUI [1])
    Methotrexate
    Code List
    Methotrexate
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Mycophenolate mofetil / Mycophenolic acid
    integer
    C0209368 (UMLS CUI [1])
    C0026933 (UMLS CUI [2])
    Mycophenolate mofetil / Mycophenolic acid
    Code List
    Mycophenolate mofetil / Mycophenolic acid
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Sulfasalazine
    integer
    C0036078 (UMLS CUI [1])
    Sulfasalazine
    Code List
    Sulfasalazine
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Teriflunomide
    integer
    C1718383 (UMLS CUI [1])
    Teriflunomide
    Code List
    Teriflunomide
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item Group
    Chemotherapeutics: Cytostatics
    C0010858 (UMLS CUI-1)
    C0729502 (UMLS CUI-2)
    Item
    Cladribine (2-CDA) i.v./s.c. (in the last 12 months)
    integer
    C0092801 (UMLS CUI [1,1])
    C0348016 (UMLS CUI [1,2])
    C0332185 (UMLS CUI [1,3])
    C0092801 (UMLS CUI [2,1])
    C0021499 (UMLS CUI [2,2])
    C0332185 (UMLS CUI [2,3])
    Cladribine (2-CDA) i.v./s.c. (in the last 12 months)
    Code List
    Cladribine (2-CDA) i.v./s.c. (in the last 12 months)
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Cladribine (2-CDA) p.o. (in the last 12 months)
    integer
    C0092801 (UMLS CUI [1,1])
    C0001563 (UMLS CUI [1,2])
    C0332185 (UMLS CUI [1,3])
    Cladribine (2-CDA) p.o. (in the last 12 months)
    Code List
    Cladribine (2-CDA) p.o. (in the last 12 months)
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Cyclophosphamide i.v.(in the last 3 months)
    integer
    C0010583 (UMLS CUI [1,1])
    C0348016 (UMLS CUI [1,2])
    C0332185 (UMLS CUI [1,3])
    Cyclophosphamide i.v.(in the last 3 months)
    Code List
    Cyclophosphamide i.v.(in the last 3 months)
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Cyclophosphamide p.o. (in the last 3 months)
    integer
    C0010583 (UMLS CUI [1,1])
    C0001563 (UMLS CUI [1,2])
    C0332185 (UMLS CUI [1,3])
    Cyclophosphamide p.o. (in the last 3 months)
    Code List
    Cyclophosphamide p.o. (in the last 3 months)
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Mitoxantrone (in the last 3 months)
    integer
    C0026259 (UMLS CUI [1,1])
    C0332185 (UMLS CUI [1,2])
    Mitoxantrone (in the last 3 months)
    Code List
    Mitoxantrone (in the last 3 months)
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item Group
    Other Chemotherapeutics
    C0205394 (UMLS CUI-1)
    C0729502 (UMLS CUI-2)
    Item
    Other Chemotherapeutics
    integer
    C0205394 (UMLS CUI [1,1])
    C0729502 (UMLS CUI [1,2])
    Other Chemotherapeutics
    Code List
    Other Chemotherapeutics
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Other Chemotherapeutics, to specify
    Item
    Other, please specify:
    text
    C0729502 (UMLS CUI [1,1])
    C0205394 (UMLS CUI [1,2])
    C1521902 (UMLS CUI [1,3])
    Item Group
    Inhibitors: Calcineurin inhibitors
    C1562036 (UMLS CUI-1)
    Item
    Ciclosporin
    integer
    C0010592 (UMLS CUI [1])
    Ciclosporin
    Code List
    Ciclosporin
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Pimecrolimus
    integer
    C1099414 (UMLS CUI [1])
    Pimercrolimus
    Code List
    Pimecrolimus
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Tacrolimus
    integer
    C0085149 (UMLS CUI [1])
    Tacrolimus
    Code List
    Tacrolimus
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item Group
    Inhibitors: Interleukin inhibitor
    C3653320 (UMLS CUI-1)
    Item
    Anakinra
    integer
    C0245109 (UMLS CUI [1])
    Anakinra
    Code List
    Anakinra
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item Group
    Inhibitors: JAK inhibitors
    C3854325 (UMLS CUI-1)
    Item
    Baricitinib
    integer
    C4044947 (UMLS CUI [1])
    Baricitinib
    Code List
    Baricitinib
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Fedratinib
    integer
    C3886623 (UMLS CUI [1])
    Fedratinib
    Code List
    Fedratinib
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Ruxolitinib
    integer
    C2931926 (UMLS CUI [1])
    Ruxolitinib
    Code List
    Ruxolitinib
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Tofacitinib
    integer
    C2930696 (UMLS CUI [1])
    Tofacitinib
    Code List
    Tofacitinib
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Upadacitinib
    integer
    C4726929 (UMLS CUI [1])
    Upadacitinib
    Code List
    Upadacitinib
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item Group
    Inhibitors: mTOR inhibitors
    C2746052 (UMLS CUI-1)
    Item
    Everolimus
    integer
    C0541315 (UMLS CUI [1])
    Everolimus
    Code List
    Everolimus
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Sirolimus
    integer
    C0072980 (UMLS CUI [1])
    Sirolimus
    Code List
    Sirolimus
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item Group
    Inhibitor: PDE-4-inhibitor
    C2936609 (UMLS CUI-1)
    Item
    Apremilast
    integer
    C1678805 (UMLS CUI [1])
    Apremilast
    Code List
    Apremilast
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item Group
    Other Inhibitors
    C0205394 (UMLS CUI-1)
    C0243077 (UMLS CUI-2)
    Item
    Other inhibitors
    integer
    C0205394 (UMLS CUI [1,1])
    C0243077 (UMLS CUI [1,2])
    Other inhibitors
    Code List
    Other inhibitors
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Other inhibitors, to specify
    Item
    Other, please specify
    text
    C0205394 (UMLS CUI [1,1])
    C1521902 (UMLS CUI [1,2])
    C0243077 (UMLS CUI [1,3])
    Item Group
    Other immunsuppressive regimens: Corticosteroids
    C0021081 (UMLS CUI-1)
    C0205394 (UMLS CUI-2)
    C0001617 (UMLS CUI-3)
    Item
    < 10 mg / d prednisolone equivalent
    integer
    C0445550 (UMLS CUI [1,1])
    C0038317 (UMLS CUI [1,2])
    < 10 mg / d prednisolone equivalent
    Code List
    < 10 mg / d prednisolone equivalent
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    10 - 100 mg / d prednisolone equivalent
    integer
    C0038317 (UMLS CUI [1])
    10 - 100 mg / d prednisolone equivalent
    Code List
    10 - 100 mg / d prednisolone equivalent
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    > 100 mg / d prednisolone equivalent
    integer
    C0038317 (UMLS CUI [1,1])
    C0444956 (UMLS CUI [1,2])
    10 - 100 mg / d prednisolone equivalent
    Code List
    > 100 mg / d prednisolone equivalent
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item Group
    Other immunsuppressive regimens: Fumarate
    C0021081 (UMLS CUI-1)
    C0205394 (UMLS CUI-2)
    C0220833 (UMLS CUI-3)
    Item
    Dimethyl fumarate
    integer
    C0058218 (UMLS CUI [1])
    Dimethyl fumarate
    Code List
    Dimethyl fumarate
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Dimethyl fumarate / ethyl hydrogen fumarate
    integer
    C0058218 (UMLS CUI [1])
    C0059764 (UMLS CUI [2])
    Dimethyl fumarate / ethyl hydrogen fumarate
    Code List
    Dimethyl fumarate / ethyl hydrogen fumarate
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item Group
    Other immunsuppressive regimens: Immunosuppressive / immunomodulatory regimens
    C1963758 (UMLS CUI-1)
    C0205394 (UMLS CUI-2)
    C0021081 (UMLS CUI-3)
    Item
    Immunoglobulins i.v.
    integer
    C0021027 (UMLS CUI [1,1])
    C0348016 (UMLS CUI [1,2])
    Immunoglobulins i.v.
    Code List
    Immunoglobulins i.v.
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Immunoglobulins s.c.
    integer
    C0021027 (UMLS CUI [1,1])
    C0021499 (UMLS CUI [1,2])
    Immunoglobulins s.c.
    Code List
    Immunoglobulins s.c.
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item Group
    Other immunsuppressive regimens: Interferon
    C0021081 (UMLS CUI-1)
    C0205394 (UMLS CUI-2)
    C3652465 (UMLS CUI-3)
    Item
    Interferon-alpha
    integer
    C0002199 (UMLS CUI [1])
    Interferon-alpha
    Code List
    Interferon-alpha
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Interferon-beta
    integer
    C0015980 (UMLS CUI [1])
    Interferon-beta
    Code List
    Interferon-beta
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item Group
    Other Immunsuppressive regimens: Other MS drugs
    C0021081 (UMLS CUI-1)
    C0205394 (UMLS CUI-2)
    C0013227 (UMLS CUI-3)
    C0026769 (UMLS CUI-4)
    Item
    Glatirameracetat
    integer
    C0289884 (UMLS CUI [1])
    Glatirameracetat
    Code List
    Glatirameracetat
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item Group
    Other Immunsuppressive regimens: Sphingosine-1-phosphate receptor modulators
    C0021081 (UMLS CUI-1)
    C0205394 (UMLS CUI-2)
    C4760638 (UMLS CUI-3)
    Item
    Fingolimod
    integer
    C1699926 (UMLS CUI [1])
    Fingolimod
    Code List
    Fingolimod
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Siponimod
    integer
    C3657824 (UMLS CUI [1])
    Siponimod
    Code List
    Siponimod
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item Group
    Other immunosuppressive regimens: Other
    C0205394 (UMLS CUI-1)
    C0021081 (UMLS CUI-2)
    Item
    Other Immunsuppressive agents
    integer
    C0021081 (UMLS CUI [1,1])
    C0205394 (UMLS CUI [1,2])
    Other Immunsuppressive agents
    Code List
    Other Immunsuppressive agents
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Other Immunsuppressive agents, to specify
    Item
    Other, please specify
    text
    C0021081 (UMLS CUI [1,1])
    C0205394 (UMLS CUI [1,2])
    C1521902 (UMLS CUI [1,3])
    Item Group
    Immunosuppressive drugs: Underlying disease
    C0021081 (UMLS CUI-1)
    C0277554 (UMLS CUI-2)
    Item
    Multiple Sclerosis
    integer
    C0026769 (UMLS CUI [1])
    Multiple Sclerosis
    Code List
    Multiple Sclerosis
    CL Item
    not quoted (0)
    CL Item
    quoted (1)
    Item
    Other neurological autoimmune diseases
    integer
    C0205494 (UMLS CUI [1,1])
    C0004364 (UMLS CUI [1,2])
    C0205394 (UMLS CUI [1,3])
    Other neurological autoimmune diseases
    Code List
    Other neurological autoimmune diseases
    CL Item
    not quoted (0)
    CL Item
    quoted (1)
    Item
    Oncology
    integer
    C0205478 (UMLS CUI [1])
    Oncology
    Code List
    Oncology
    CL Item
    not quoted (0)
    CL Item
    quoted (1)
    Item
    Organ transplantation
    integer
    C0029216 (UMLS CUI [1])
    Organ transplantation
    Code List
    Organ transplantation
    CL Item
    not quoted (0)
    CL Item
    quoted (1)
    Item
    Rheumatic diseases
    integer
    C3495832 (UMLS CUI [1])
    Rheumatic diseases
    Code List
    Rheumatic diseases
    CL Item
    not quoted (0)
    CL Item
    quoted (1)
    Item
    Other Underlying disease
    integer
    C0277554 (UMLS CUI [1,1])
    C0205394 (UMLS CUI [1,2])
    Other Underlying disease
    Code List
    Other Underlying disease
    CL Item
    not quoted (0)
    CL Item
    quoted (1)
    Item
    Other, please specify:
    integer
    C0277554 (UMLS CUI [1,1])
    C0205394 (UMLS CUI [1,2])
    C1521902 (UMLS CUI [1,3])
    Other Underlying disease
    Code List
    Other, please specify:
    CL Item
    not quoted (0)
    CL Item
    quoted (1)
    Item
    Unknown underlying disease
    integer
    C0439673 (UMLS CUI [1,1])
    C0277554 (UMLS CUI [1,2])
    Unknown underlying disease
    Code List
    Unknown underlying disease
    CL Item
    not quoted (0)
    CL Item
    quoted (1)
    Item Group
    Is data entry for this section finished?
    C4684556 (UMLS CUI-1)
    C1828479 (UMLS CUI-2)
    C0205197 (UMLS CUI-3)
    Item
    Is data entry for this section finished?
    integer
    C4684556 (UMLS CUI [1,1])
    C1828479 (UMLS CUI [1,2])
    C0205197 (UMLS CUI [1,3])
    Is data entry for this section finished?
    Code List
    Is data entry for this section finished?
    CL Item
    Yes (1)
    CL Item
    No (2)
    Zum Seitenanfang zurückkehren 

    Hilfe

    Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

    Zum Video